BioSpace News Archive

Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings for the six months ended June 30, 2021.

Neurana Pharmaceuticals today announced the presentation of scientific abstracts at two congresses, the 28th Annual Napa Pain Conference August 27-28th , 2021, and PAIN Week September 7-11th , 2021.

Rapha Capital Management, LLC announces it has closed a new convertible note offering totaling US $3 million in three tranches by Rapha Capital BioVentures Fund I, LP to support the clinical development of Imagin Medical Inc.'s lead product, the i/Blue™ Imaging System.

The National Comprehensive Cancer Network® (NCCN®)—a nonprofit alliance of leading cancer centers—today announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance.

There are many anti-hangover products on the market. However, none of these utilize the key ingredient that makes Alcovit such a groundbreaking post-drinking solution.

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today that the company will participate in the H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually from September 13-15, 2021.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease diagnostics, announced today that the Company’s manufacturing partner Empowered Diagnostics has filed an amended emergency use authorization (EUA) with the Food and Drug Administration (FDA) for ImmunoPass™

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that the U.S. Food and Drug Administration (FDA) has granted LP-184 Orphan Drug Designation (ODD) for the treatment of glioblastoma multiforme (GBM) and other malignant gliomas.

Nuance Communications, Inc. (NASDAQ: NUAN) and Cooper University Health Care (Cooper) today announced a strategic collaboration to expand Cooper’s deployment of the Nuance® Dragon Ambient eXperience™ (DAX™) ambient clinical intelligence (ACI) solution to 475 physicians and advanced practice providers (APPs).

USAntibiotics, the sole licensed American maker of penicillin-based Amoxicillin and Amoxil Clavulanate, the popular antibiotics commonly known as Amoxil® and Augmentin®, today reopened its Bristol, Tenn. manufacturing facility, which had slipped into bankruptcy and ceased operations last year.